Repeated injection can also damage veins
Contains Soy (less than 5 parts per million)
Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T, Iijima M, Takekawa H, Usui I, Hiraishi H, Aso Y
Beneficiaries may need to meet requirements related to: Age Body mass index, or BMI A prescription for weight loss or maintaining weight reduction Use of the medication along with lifestyle modifications Other qualifying health conditions CMS guidance indicates that the program is designed for beneficiaries seeking GLP-1 medications solely to reduce excess body weight or maintain weight reduction
Clinical trials are necessary to establish its safety, efficacy, and appropriate human dosing